Hans Hagglund

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH. 2024;83(1):2419698
Sauna bathing in northern Sweden: results from the MONICA study 2022.
Engström Å; Hägglund H; Lee E; Wennberg M; Söderberg S; Andersson M
Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2024;26(9):792-804
Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
Iribarren C; Levedahl KH; Atanasoai I; Mattsson M; Hoglund M; Soderlund S; Hagglund H; Eriksson N; Carlson M; Nilsson GP
Article: BLOOD ADVANCES. 2024;8(11):2890-2900
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
Lübke J; Schmid A; Christen D; Oude Elberink HNG; Span LFR; Niedoszytko M; Gorska A; Lange M; Gleixner KV; Hadzijusufovic E; Stefan A; Angelova-Fischer I; Zanotti R; Bonifacio M; Bonadonna P; Shoumariyeh K; von Bubnoff N; Müller S; Perkins C; Elena C; Malcovati L; Hagglund H; Mattsson M; Parente R; Varkonyi J; Fortina AB; Caroppo F; Brockow K; Zink A; Breynaert C; Leven T; Yavuz AS; Doubek M; Sabato V; Schug T; Hartmann K; Triggiani M; Gotlib J; Hermine O; Arock M; Kluin-Nelemans HC; Panse J; Sperr WR; Valent P; Reiter A; Schwaab J
Article: ACTA ONCOLOGICA. 2024;63:44-50
Epidemiology of mastocytosis: a population-based study (Sweden)
Bergstrom A; Hagglund H; Berglund A; Nilsson G; Lambe M
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024;95(2):125-133
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
Silfverberg T; Zjukovskaja C; Ljungman P; Nahimi A; Ahlstrand E; Dreimane A; Einarsdottir S; Fagius J; Iacobaeus E; Hagglund H; Lange N; Lenhoff S; Lycke J; Mellergard J; Piehl F; Svenningsson A; Tolf A; Cherif H; Carlson K; Burman J
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2023;11(6):1706-1717
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
Valent P; Hartmann K; Bonadonna P; Sperr W; Niedoszytko M; Kluin-Nelemans HC; Hermine O; Sotlar K; Hoermann G; Nedoszytko B; Broesby-Olsen S; Zanotti R; Lange M; Doubek M; Brockow K; Alvarez-Twose I; Varkonyi J; Yavuz S; Nilsson G; Radia D; Grattan C; Schwaab J; Gillen T; Elberink HNGO; Haegglund H; Siebenhaar F; Hadzijusufovic E; Sabato V; Mayer J; Reiter A; Orfao A; Horny H-P; Triggiani M; Arock M
Article: BLOOD ADVANCES. 2023;7(9):1713-1724
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
Kennedy VE; Perkins C; Reiter A; Jawhar M; Luebke J; Kluin-Nelemans HC; Shomali W; Langford C; Abuel J; Hermine O; Niedoszytko M; Gorska A; Mital A; Bonadonna P; Zanotti R; Tanasi I; Mattsson M; Hagglund H; Triggiani M; Yavuz AS; Panse J; Christen D; Heizmann M; Shoumariyeh K; Mueller S; Elena C; Malcovati L; Fiorelli N; Wortmann F; Vucinic V; Brockow K; Fokoloros C; Papageorgiou SG; Breynaert C; Bullens D; Doubek M; Ilerhaus A; Angelova-Fischer I; Solomianyi O; Varkonyi J; Sabato V; Ruefer A; Schug TD; Hermans MAW; Fortina AB; Caroppo F; Bumbea H; Gulen T; Hartmann K; Elberink HO; Schwaab J; Arock M; Valent P; Sperr WR; Gotlib J
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2023;11(2):581-590.e5
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.
Lübke J; Schwaab J; Christen D; Elberink HO; Span B; Niedoszytko M; Gorska A; Lange M; Gleixner KV; Hadzijusufovic E; Solomianyi O; Angelova-Fischer I; Zanotti R; Bonifacio M; Bonadonna P; Shoumariyeh K; von Bubnoff N; Müller S; Perkins C; Elena C; Malcovati L; Hagglund H; Mattsson M; Parente R; Varkonyi J; Fortina AB; Caroppo F; Zink A; Brockow K; Breynaert C; Bullens D; Yavuz AS; Doubek M; Sabato V; Schug T; Niederwieser D; Hartmann K; Triggiani M; Gotlib J; Hermine O; Arock M; Kluin-Nelemans HC; Panse J; Sperr WR; Valent P; Reiter A; Jawhar M
Article: TRANSPLANTATION PROCEEDINGS. 2023;55(1):242-248
Worries and Psychological Well-Being in Potential Hematopoietic Stem Cell Donors Before Donation-A Swedish National Study
Winterling J; Pahnke S; Lagnebjork J; Hagglund H; Larfors G; Lenhoff S; Kisch AM
Article: BONE MARROW TRANSPLANTATION. 2022;57(5):795-802
Cancer incidence in healthy Swedish peripheral blood stem cell donors
Pahnke S; Nygell UA; Johansson J-E; Kisch A; Ljungman P; Sandstedt A; Hagglund H; Larfors G
Article: LEUKEMIA. 2022;36(2):516-524
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
Zanotti R; Bonifacio M; Lucchini G; Sperr WR; Scaffidi L; van Anrooij B; Oude Elberink HN; Rossignol J; Hermine O; Gorska A; Lange M; Hadzijusufovic E; Miething C; Müller S; Perkins C; Shomali W; Elena C; Illerhaus A; Jawhar M; Parente R; Caroppo F; Solomianyi O; Zink A; Mattsson M; Yavuz AS; Panse J; Varkonyi J; Doubek M; Sabato V; Breynaert C; Vucinic V; Schug T; Hägglund H; Wortmann F; Brockow K; Angelova-Fischer I; Belloni Fortina A; Triggiani M; Reiter A; Hartmann K; Malcovati L; Gotlib J; Shoumariyeh K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Bonadonna P; Valent P
Article: MEDICAL ONCOLOGY. 2021;38(6):70
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
Tesfa D; Sander B; Lindkvist H; Nilsson C; Kimby E; Hagglund H; Wahlin BE; Klimkowska M; Palmblad J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(2):290-293
Graft-versus-mastocytosis effect after donor lymphocyte infusion: Proof of principle
Hagglund H; Yavuz AS; Dreimane A; Malm C; Sundin A; Sander B; Nilsson G
Article: THERANOSTICS. 2021;11(1):292-303
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis.
Kluin-Nelemans HC; Jawhar M; Reiter A; van Anrooij B; Gotlib J; Hartmann K; Illerhaus A; Oude Elberink HNG; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Müller S; Triggiani M; Parente R; Schwaab J; Kundi M; Fortina AB; Caroppo F; Brockow K; Zink A; Fuchs D; Angelova-Fischer I; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Simonowski A; Sabato V; Schug T; Jentzsch M; Breynaert C; Várkonyi J; Kennedy V; Hermine O; Rossignol J; Arock M; Valent P; Sperr WR
Article: ALLERGY. 2020;75(8):1927-1938
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification.
Trizuljak J; Sperr WR; Nekvindová L; Elberink HO; Gleixner KV; Gorska A; Lange M; Hartmann K; Illerhaus A; Bonifacio M; Perkins C; Elena C; Malcovati L; Fortina AB; Shoumariyeh K; Jawhar M; Zanotti R; Bonadonna P; Caroppo F; Zink A; Triggiani M; Parente R; von Bubnoff N; Yavuz AS; Hägglund H; Mattsson M; Panse J; Jäkel N; Kilbertus A; Hermine O; Arock M; Fuchs D; Sabato V; Brockow K; Bretterklieber A; Niedoszytko M; van Anrooij B; Reiter A; Gotlib J; Kluin-Nelemans HC; Mayer J; Doubek M; Valent P
Article: LEUKEMIA. 2020;34(4):1090-1101
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.
Kluin-Nelemans HC; Reiter A; Illerhaus A; van Anrooij B; Hartmann K; Span LFR; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Parente R; Triggiani M; Schwaab J; Jawhar M; Caroppo F; Fortina AB; Brockow K; Zink A; Fuchs D; Kilbertus A; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Sabato V; Aberer E; Niederwieser D; Breynaert C; Várkonyi J; Kennedy V; Lortholary O; Jakob T; Hermine O; Rossignol J; Arock M; Gotlib J; Valent P; Sperr WR
Article: BONE MARROW TRANSPLANTATION. 2020;55(2):283-306
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE).
Sharrack B; Saccardi R; Alexander T; Badoglio M; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro PA; Rovira M; Sormani MP; Snowden JA; European Society for Blood and Marrow Transplantat
Article: LANCET HAEMATOLOGY. 2019;6(12):e638-e649
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.
Sperr WR; Kundi M; Alvarez-Twose I; van Anrooij B; Oude Elberink JNG; Gorska A; Niedoszytko M; Gleixner KV; Hadzijusufovic E; Zanotti R; Bonadonna P; Bonifacio M; Perkins C; Illerhaus A; Elena C; Merante S; Shoumariyeh K; von Bubnoff N; Parente R; Jawhar M; Belloni Fortina A; Caroppo F; Brockow K; Zink A; Fuchs D; Kilbertus AJ; Yavuz AS; Doubek M; Hägglund H; Panse J; Sabato V; Bretterklieber A; Niederwieser D; Breynaert C; Hartmann K; Triggiani M; Nedoszytko B; Reiter A; Orfao A; Hermine O; Gotlib J; Arock M; Kluin-Nelemans HC; Valent P
Article: CLINICAL TRANSPLANTATION. 2019;33(12):e13742
Bone and hormonal status 10 years post-allogeneic bone marrow transplantation
Gubrianska D; Machaczka M; Hassan M; Hagglund H; Ljungman P; Palmer M
Article: BONE MARROW TRANSPLANTATION. 2019;54(6):858-866
Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.
Pahnke S; Egeland T; Halter J; Hägglund H; Shaw BE; Woolfrey AE; Szer J; Working Group Medical of the World Marrow Donor As
Article: CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;44(1):84-91
Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
Afram G; Watz E; Remberger M; Nygell UA; Sundin M; Hagglund H; Mattsson J; Uhlin M
Article: JOURNAL OF CLINICAL APHERESIS. 2018;33(3):226-235
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
Pahnke S; Larfors G; Axdorph-Nygell U; Fischer-Nielsen A; Haastrup E; Heldal D; Itala-Remes M; Johansson J-E; Kauppila M; Lenhoff S; Ljungman P; Niittyvuopio R; Sandstedt A; Hagglund H
Article: MEDICAL ONCOLOGY. 2018;35(6):79
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
Afram G; Perez-Simon JA; Remberger M; Caballero-Velazquez T; Martino R; Luis Pinana J; Ringden O; Esquirol A; Lopez-Corral L; Garcia I; Lopez-Godino O; Sierra J; Caballero D; Ljungman P; Vazquez L; Hagglund H
Article: JOURNAL OF CLINICAL APHERESIS. 2017;32(6):384-391
G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield
Machaczka M; Hagglund H; Staver E; Joks M; Hassan M; Wahlin BE; Nygell UA
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):44
Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab
Ajeganova S; Tesfa D; Hgglund H; Fadeel B; Vedin I; Zignego AL; Palmblad J
Article: ONCOTARGET. 2017;8(6):9647-9659
Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis
Lyberg K; Ali HA; Grootens J; Kjellander M; Tirfing M; Arock M; Hagglund H; Nilsson G; Ungerstedt J
Article: NEUROMUSCULAR DISORDERS. 2017;27(1):90-93
Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report
Hakansson I; Sandstedt A; Lundin F; Askmark H; Pirskanen R; Carlson K; Piehl F; Hagglund H
Article: ACTA DERMATO-VENEREOLOGICA. 2016;96(5):602-612
Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus
Broesby-Olsen S; Dybedal I; Gulen T; Kristensen TK; Moller MB; Ackermann L; Saaf M; Karlsson M; Agertoft L; Brixen K; Hermann P; Stylianou E; Mortz CG; Torfing T; Havelund T; Sander B; Bergstrom A; Bendix M; Garvey LH; Weis Bjerrum O; Valent P; Bindslev-Jensen C; Nilsson G; Vestergaard H; Hagglund H
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2016;137(1):35-45
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Hartmann K; Escribano L; Grattan C; Brockow K; Carter MC; Alvarez-Twose I; Matito A; Broesby-Olsen S; Siebenhaar F; Lange M; Niedoszytko M; Castells M; Oude Elberink JNG; Bonadonna P; Zanotti R; Hornick JL; Torrelo A; Grabbe J; Rabenhorst A; Nedoszytko B; Butterfield JH; Gotlib J; Reiter A; Radia D; Hermine O; Sotlar K; George TI; Kristensen TK; Kluin-Nelemans HC; Yavuz S; Hagglund H; Sperr WR; Schwartz LB; Triggiani M; Maurer M; Nilsson G; Horny H-P; Arock M; Orfao A; Metcalfe DD; Akin C; Valent P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(12):2052-2060
Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
Worel N; Buser A; Greinix HT; Hägglund H; Navarro W; Pulsipher MA; Nicoloso de Faveri G; Bengtsson M; Billen A; Espino G; Fechter M; Giudice V; Hölig K; Kanamori H; Kodera Y; Leitner G; Netelenbos T; Niederwieser D; van Walraven SM; Rocha V; Torosian T; Vergueiro C; Weisdorf D; Yabe H; Halter JP
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2015;4(10):1199-1213
In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalen M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OPB; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson P-O; Haegglund H; Mattsson M; Lentio J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo K-H; Le Blanc K
Article: MEDICAL ONCOLOGY. 2015;32(4):135
Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study
Bergfelt E; Kozlowski P; Ahlberg L; Hulegardh E; Hagglund H; Karlsson K; Markuszewska-Kuczymska A; Tomaszewska-Toporska B; Smedmyr B; Astrom M; Amini R-M; Hallbook H
Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(2):189-197
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party
Greco R; Bondanza A; Oliveira MC; Badoglio M; Burman J; Piehl F; Hagglund H; Krasulova E; Simoes BP; Carlson K; Pohlreich D; Labopin M; Saccardi R; Comi G; Mancardi GL; Bacigalupo A; Ciceri F; Farge D
Article: ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2015;63(1):65-71
Impact of Imiglucerase Supply Shortage on Clinical and Laboratory Parameters in Norrbottnian Patients with Gaucher Disease Type 3
Machaczka M; Bjorkvall CK; Wieremiejczyk J; Arce MP; Myhr-Eriksson K; Klimkowska M; Hagglund H; Svenningsson P
Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(29):3264-3274
Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
Ustun C; Reiter A; Scott BL; Nakamura R; Damaj G; Kreil S; Shanley R; Hogan WJ; Perales M-A; Shore T; Baurmann H; Stuart R; Gruhn B; Doubek M; Hsu JW; Tholouli E; Gromke T; Godley LA; Pagano L; Gilman A; Wagner EM; Shwayder T; Bornhaeuser M; Papadopoulos EB; Boehm A; Vercellotti G; Van Lint MT; Schmid C; Rabitsch W; Pullarkat V; Legrand F; Yakoub-agha I; Saber W; Barrett J; Hermine O; Hagglund H; Sperr WR; Popat U; Alyea EP; Devine S; Deeg HJ; Weisdorf D; Akin C; Valent P
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2014;85(10):1116-1121
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Burman J; Iacobaeus E; Svenningsson A; Lycke J; Gunnarsson M; Nilsson P; Vrethem M; Fredrikson S; Martin C; Sandstedt A; Uggla B; Lenhoff S; Johansson J-E; Isaksson C; Hagglund H; Carlson K; Fagius J
Article: ACTA DERMATO-VENEREOLOGICA. 2014;94(5):583-584
Increased Risk of Malignant Melanoma in Patients with Systemic Mastocytosis?
Hagglund H; Sander B; Gulen T; Lindelof B; Nilsson G
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(9):1179-1187
The presence of mast cell clonality in patients with unexplained anaphylaxis
Gulen T; Hagglund H; Sander B; Dahlen B; Nilsson G
Article: MEDICAL ONCOLOGY. 2014;31(8):66
Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study
Hulegardh E; Hagglund H; Ahlberg L; Karlsson K; Karbach H; Markuszewska A; Persson I; Astrom M; Hallbook H
Article: MEDICAL ONCOLOGY. 2014;31(8):123
Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis
Hagglund H; Sander B; Ahmadi A; Gulen T; Nilsson G
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2014;85(6):618-624
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP
Press R; Askmark H; Svenningsson A; Andersen O; Axelson HW; Stroemberg U; Wahlin A; Isaksson C; Johansson J-EJ; Haegglund H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2014;92(5):377-381
High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden
Kozlowski P; Astrom M; Ahlberg L; Bernell P; Hulegardh E; Hagglund H; Karlsson K; Markuszewska-Kuczymska A; Tomaszewska-Toporska B; Smedmyr B; Amini R-M; Hallbook H
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(1):121-129
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
Gulen T; Hagglund H; Dahlen B; Nilsson G
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(1):135-138
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.
Ruutu T; Juvonen E; Remberger M; Remes K; Volin L; Mattsson J; Nihtinen A; Hägglund H; Ringdén O; Nordic Group for Blood and Marrow Transplantation
Article: NORDIC PULP & PAPER RESEARCH JOURNAL. 2013;28(4):596-601
Prediction of optical variations in paper from high resolution measurements of paper properties
Hagglund H; Norberg O; Edstrom P
Article: MEDICAL ONCOLOGY. 2013;30(4):762
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse
Machaczka M; Johansson J-E; Remberger M; Hallbook H; Lazarevic VL; Wahlin BE; Omar H; Wahlin A; Juliusson G; Kimby E; Hagglund H
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Dahllof G; Mattsson J; Ljungman P; Remberger M
Article: CLINICAL AND TRANSLATIONAL ALLERGY. 2013;3(1):22
The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.
Gülen T; Dahlén B; Sander B; Hägglund H; Nilsson G
Article: CLINICAL TRANSPLANTATION. 2013;27(4):E368-E374
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors
Remberger M; Ringden O; Hagglund H; Svahn B-M; Ljungman P; Uhlin M; Mattsson J
Article: SKELETAL MUSCLE. 2013;3(1):12
Bone marrow derived cells in adult skeletal muscle tissue in humans
Stroemberg A; Jansson M; Fischer H; Rullman E; Haegglund H; Gustafsson T
Article: BONE MARROW TRANSPLANTATION. 2013;48(2):220-225
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)
Halter JP; van Walraven SM; Worel N; Bengtsson M; Hagglund H; de Faveri GN; Shaw BE; Schmidt AH; Fechter M; Madrigal A; Szer J; Aljurf MD; Weisdorf D; Horowitz MM; Greinix H; Niederwieser D; Gratwohl A; Kodera Y; Confer D
Article: NORDIC PULP & PAPER RESEARCH JOURNAL. 2013;28(1):131-136
Non-destructive high resolution measurements of spatial filler content distribution in paper
Hagglund H; Norberg O; Edstrom P
Article: MEDICAL ONCOLOGY. 2012;29(4):2348-2358
Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution
Nahi H; Remberger M; Machaczka M; Ungerstedt J; Mattson J; Ringden O; Le-Blanc K; Ljungman P; Hagglund H
Article: MEDICAL ONCOLOGY. 2012;29(5):3540-3546
Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm
Gulen T; Sander B; Nilsson G; Palmblad J; Sotlar K; Horny H-P; Hagglund H
Article: CELL DEATH & DISEASE. 2012;3(11):e417
Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation
Westerberg CM; Hagglund H; Nilsson G
Article: HAEMATOLOGICA. 2012;97(9):1414-1421
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007
Kozlowski P; Astrom M; Ahlberg L; Bernell P; Hulegardh E; Hagglund H; Karlsson K; Markuszewska-Kuczymska A; Tomaszewska-Toporska B; Smedmyr B; Hallbook H
Article: LEUKEMIA & LYMPHOMA. 2012;53(9):1699-1705
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
Machaczka M; Johansson J-E; Remberger M; Hallbook H; Malm C; Lazarevic VL; Wahlin A; Omar H; Juliusson G; Kimby E; Hagglund H
Article: MEDICAL ONCOLOGY. 2012;29(3):2070-2076
Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results
Machaczka M; Wahlin BE; Piatkowska-Jakubas B; Rucinska M; Jurczak W; Balana-Nowak A; Klimkowska M; Hagglund H; Skotnicki AB
Article: HAEMATOLOGICA. 2012;97(8):1187-1195
Evaluation of prognostic factors among patients with chronic graft-versus-host disease
Perez-Simon JA; Afram G; Martino R; Pinana JL; Caballero-Velazquez T; Ringden O; Valcarcel D; Caballero D; Remberger M; de Paz Y; Sierra J; San Miguel J; Hagglund H
Article: ADVANCES IN MEDICAL SCIENCES. 2012;57(1):169-173
Unexpected cure from cutaneous leukocytoclastic vasculitis in a patient treated with N-butyldeoxynojirimycin (miglustat) for Gaucher disease
Machaczka M; Klimkowska M; Hagglund H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(4):557-564
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
von Bahr L; Sundberg B; Lonnies L; Sander B; Karbach H; Hagglund H; Ljungman P; Gustafsson B; Karlsson H; Le Blanc K; Ringden O
Article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2012;117(1):28-34
Substrate reduction therapy with miglustat for type 1 Gaucher disease: A retrospective analysis from a single institution
Machaczka M; Hast R; Dahlman I; Lerner R; Klimkowska M; Engvall M; Hagglund H
Article: LEUKEMIA & LYMPHOMA. 2012;53(1):139-144
Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia
Yakimchuk K; Norin S; Kimby E; Hagglund H; Warner M; Gustafsson J-A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: CANCER. 2011;117(18):4238-4246
Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006
Juliusson G; Karlsson K; Lazarevic VL; Wahlin A; Brune M; Antunovic P; Derolf A; Hagglund H; Karbach H; Lehmann S; Mollgard L; Stockelberg D; Hallbook H; Hoglund M
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2011;86(8):709-710
Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: A retrospective study
Lazarevic VL; Remberger M; Hagglund H; Hallbook H; Juliusson G; Kimby E; Malm C; Wahlin A; Omar H; Johansson J-E
Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(8):2209-2214
Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections
Tesfa D; Ajeganova S; Hagglund H; Sander B; Fadeel B; Hafstrom I; Palmblad J
Article: BONE MARROW TRANSPLANTATION. 2011;46(6):870-875
Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder
Johansson J-E; Remberger M; Lazarevic VL; Hallbook H; Wahlin A; Kimby E; Juliusson G; Omar H; Hagglund H
Article: MEDICAL ONCOLOGY. 2011;28(2):552-558
Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts
Wahlin A; Lorenz F; Fredriksson M; Remberger M; Wahlin BE; Hagglund H
Article: MEDICAL ONCOLOGY. 2011;28(2):539-543
Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma
Machaczka M; Vaktnas J; Klimkowska M; Nahi H; Hagglund H
Article: LEUKEMIA & LYMPHOMA. 2011;52(4):613-619
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center
Machaczka M; Vaktnas J; Klimkowska M; Hagglund H
Article: PEDIATRIC BLOOD & CANCER. 2011;56(3):444-451
Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia
Carlsson G; Winiarski J; Ljungman P; Ringden O; Mattsson J; Nordenskjold M; Touw I; Henter J-I; Palmblad J; Fadeel B; Hagglund H
Article: LEUKEMIA & LYMPHOMA. 2011;52(1):69-71
Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden
Lazarevic VL; Hagglund H; Remberger M; Wahlin A; Hallbook H; Juliusson G; Kimby E; Malm C; Omar H; Johansson J-E
Article: BONE MARROW TRANSPLANTATION. 2010;45(1):53-61
Comparison of general vs regional anaesthesia for BM harvesting: a retrospective study of anaesthesia-related complications
Machaczka M; Kalaitzakis E; Eleborg L; Ljungman P; Hagglund H
Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2009;32(6):758-761
Effort bruising disclosing Gaucher disease in a 55-year-old non-Jewish woman
Machaczka M; Klimkowska M; Hagglund H
Article: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):393-399
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
Omar H; Hagglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(9):1108-1115
Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies
Le Blanc K; Barrett AJ; Schaffer M; Hagglund H; Ljungman P; Ringden O; Remberger M
Article: HAEMATOLOGICA. 2008;93(11):1734-1738
An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients
Nahi H; Hagglund H; Ahlgren T; Bernell P; Hardling M; Karlsson K; Lazarevic VL; Linderholm M; Smedmyr B; Astrom M; Hallbook H
Article: BONE MARROW TRANSPLANTATION. 2008;41(10):895-904
The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model
Sadeghi B; Jansson M; Hassan Z; Mints M; Hagglund H; Abedi-Valugerdi M; Hassan M
Article: MEDICAL ONCOLOGY. 2008;25(4):374-379
Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
Tesfa D; Gelius T; Sander B; Kimby E; Fadeel B; Palmblad J; Hagglund H
Article: BONE MARROW TRANSPLANTATION. 2007;40(9):865-869
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT
Avetisyan G; Aschan J; Haegglund H; Ringden O; Ljungman P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2007;137(2):166-169
Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia
Karlsson J; Carlsson G; Ramme KG; Hagglund H; Nordenskjold M; Henter J-I; Palmblad J; Putsep K; Andersson M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2006;77(3):203-209
Portal vein thrombosis is a common complication following splenectomy in patients with malignant haematological diseases
Svensson M; Wiren M; Kimby E; Hagglund H
Article: BONE MARROW TRANSPLANTATION. 2005;35(12):1141-1148
Autologous and allogeneic stem cell transplantation in adult ALL:: the Swedish Adult ALL Group experience
Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B
Article: MEDICAL ONCOLOGY. 2004;21(3):273-284
Posttransplant lymphoma -: A single-center experience of 500 liver transplantations
Norin S; Kimby E; Ericzon BG; Christensson B; Sander B; Söderdahl G; Häggland H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2003;9(7):472-481
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Doney K; Hägglund H; Leisenring W; Chauncey T; Appelbaum FR; Storb R
Article: BLOOD. 2002;100(6):1977-1983
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation
Ruutu T; Eriksson B; Remes K; Juvonen E; Volin L; Remberger M; Parkkali T; Hägglund H; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2002;30(3):141-147
The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo
Hassan Z; Hellström-Lindberg E; Alsadi S; Edgren M; Hägglund H; Hassan M
Article: EUROPEAN JOURNAL OF CANCER CARE. 2001;10(2):124-130
Health-related duality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation
Edman L; Larsen J; Hägglund H; Gardulf A
Article: TRANSPLANTATION. 2000;69(10):2043-2048
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer
Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
Article: CLINICAL TRANSPLANTATION. 1999;13(6):512-519
Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease:: a long-term follow-up
Aschan J; Carlens S; Hägglund H; Klaesson S; Mattsson J; Remberger M
Article: BONE MARROW TRANSPLANTATION. 1999;24(9):1033-1035
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients
Hentschke P; Hägglund H; Mattsson J; Carlens S; Lönnqvist B; Ljungman P; Aschan J; Fredrikson S; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1999;24(8):831-836
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation
Hägglund H; Ringdén O; Öman S; Remberger M; Carlens S; Mattsson J
Article: BLOOD. 1999;94(2):455-464
Peripheral blood stem cell transplantation from unrelated donors:: A comparison with marrow transplantation
Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau IW; Basara N; Hölig K; Beelen DW; Hägglund H; Basu O; Ehninger G; Fauser AA
Article: CLINICAL INFECTIOUS DISEASES. 1999;28(3):562-568
Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients:: Does it wave clinical significance?
Wang FZ; Linde A; Hägglund A; Testa M; Locasciulli A; Ljungman P
Article: BLOOD. 1998;92(12):4568-4572
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation
Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
Article: BLOOD. 1998;92(10):3599-3604
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.
Carreras E; Bertz H; Arcese W; Vernant JP; Tomás JF; Hagglund H; Bandini G; Esperou H; Russell J; de la Rubia J; Di Girolamo G; Demuynck H; Hartmann O; Clausen J; Ruutu T; Leblond V; Iriondo A; Bosi A; Ben-Bassat I; Koza V; Gratwohl A; Apperley JF
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):795-800
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection
Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):755-761
Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Article: TRANSPLANTATION. 1998;66(5):620-625
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including, anti-T-cell antibodies
Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(5):499-501
Detection of hepatitis G virus GB virus C after allogeneic bone marrow transplantation
Ljungman P; Halasz R; Hägglund H; Sönnerborg A; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(2):131-136
Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow
Hägglund H; Ringdén O; Remberger M; Lönnqvist B; Sparrelid E; Tammik L; Kumlien G
Article: BONE MARROW TRANSPLANTATION. 1998;22(1):73-78
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation
Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Article: CLINICAL TRANSPLANTATION. 1998;12(2):84-92
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination
Carlens S; Ringden O; Aschan J; Hagglund H; Ljungman P; Mattsson J; Remberger M
Article: BONE MARROW TRANSPLANTATION. 1998;21(4):331-335
Intraosseous compared to intravenous infusion of allogeneic bone marrow
Hägglund H; Ringdén O; Ågren B; Wennberg L; Remberger M; Rundquist L; Svahn BM; Aspelin P
Article: BONE MARROW TRANSPLANTATION. 1998;21(1):43-49
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age
Ringdén O; Remberger M; Mattsson J; Aschan J; Carlens S; Hägglund H; Lönnqvist B; Sparrelid E; Ljungman P
Article: SUPPORTIVE CARE IN CANCER. 1997;5(6):485-488
Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study
Ljungman P; Hagglund H; Bjorkstrand B; Lonnqvist B; Ringden O
Article: TRANSPLANTATION. 1997;64(8):1207-1208
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation on for non-A, non-B, non-C hepatitis
Hagglund H; Winiarski J; Ringden O; Sparrelid E; Ericzon BG
Article: TRANSPLANTATION. 1996;62(8):1076-1080
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ericzon BG; Duraj F; Ljungman P; Lonnqvist B; Winiarski J; Tyden G
Article: CLINICAL INFECTIOUS DISEASES. 1996;23(1):167-169
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation
Ljungman P; Andersson J; Aschan J; Bjorkstrand B; Hagglund H; Lonnqvist B; Ringden O; Winiarski J
Article: TRANSPLANTATION. 1995;60(11):1225-1230
Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Klaesson S; Ringden O; Ljungman P; Aschan J; Hagglund H; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1995;16(6):747-753
Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients
Hagglund H; Bostrom L; Remberger M; Ljungman P; Nilsson B; Ringden O
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625
SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B AND HLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS
RINGDEN O; REMBERGER M; PERSSON U; LJUNGMAN P; ALDENER A; ANDSTROM E; ASCHAN J; BOLME P; DAHLLOF G; DALIANIS T; GAHRTON G; HAGGLUND H; LONNQVIST B; OLERUP O; SHANWELL A; SPARRELID E; WINIARSKI J; MOLLER E; OBERG M
Visa fler

Alla övriga publikationer

Letter: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2022;76(10):526-527
No evidence for transmission of psychosis, bipolar or depressive disorder via hematopoietic stem cell transplantation: A Swedish registry study
Ekstrom LD; Pahnke S; Larfors G; Hagglund H; Lekander M; Edgren G; Cervenka S
Editorial comment: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(2):168
Sauna bathing and lower urinary tract symptoms- the heat is on?
Hägglund H
Editorial comment: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(1):83
Title sauna bathing and lower urinary tract symptoms - the heat is on?
Hägglund H
Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2019;7(1):81-87
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.
Valent P; Oude Elberink JNG; Gorska A; Lange M; Zanotti R; van Anrooij B; Bonifacio M; Bonadonna P; Gleixner KV; Hadzijusufovic E; Perkins C; Hartmann K; Illerhaus A; Merante S; Elena C; Shoumariyeh K; von Bubnoff N; Parente R; Triggiani M; Schwaab J; Jawhar M; Caroppo F; Fortina AB; Brockow K; David Fuchs; Greul R; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Sabato V; Aberer E; Al-Ali HK; Morren M-A; Varkonyi J; Zink A; Niedoszytko M; Niederwieser D; Malcovati L; Reiter A; Kennedy V; Gotlib J; Lortholary O; Hermine O; Arock M; Kluin-Nelemans H; Sperr WR; Study Group of the European Competence Network on
Review: CLINICAL CARDIOLOGY. 2018;41(11):1491-1501
Effects of sauna bath on heart failure: A systematic review and meta-analysis.
Källström M; Soveri I; Oldgren J; Laukkanen J; Ichiki T; Tei C; Timmerman M; Berglund L; Hägglund H
Review: LAKARTIDNINGEN. 2018;115:FASY
[Cutaneous mastocytosis - update and clinical guidelines].
Bergström A; Rollman O; Emtestam L; Mattson M; Hägglund H; Nilsson G; Karlsson M
Review: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2018;89(2):147-155
Autologous haematopoietic stem cell transplantation for neurological diseases.
Burman J; Tolf A; Hägglund H; Askmark H
Letter: LEUKEMIA. 2016;30(9):1953-1956
Detection of circulating mast cells in advanced systemic mastocytosis
Dahlin JS; Ungerstedt JS; Grootens J; Sander B; Guelen T; Haegglund H; Nilsson G
Editorial comment: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(8):1348-1356
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.
Ustun C; Gotlib J; Popat U; Artz A; Litzow M; Reiter A; Nakamura R; Kluin-Nelemans HC; Verstovsek S; Gajewski J; Perales M-A; George T; Shore T; Sperr W; Saber W; Kota V; Yavuz AS; Pullarkat V; Rogosheske J; Hogan W; Van Besien K; Hagglund H; Damaj G; Arock M; Horny H-P; Metcalfe DD; Deeg HJ; Devine S; Weisdorf D; Akin C; Valent P
Review: JOURNAL OF INTERNAL MEDICINE. 2016;279(3):211-228
Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease
Gulen T; Hagglund H; Dahlen B; Nilsson G
Letter: BONE MARROW TRANSPLANTATION. 2014;49(12):1541-1542
Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation
Hagglund H; Remberger M; Ringden O
Review: ANNALS OF ONCOLOGY. 2014;25(9):1691-1700
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal
Valent P; Sotlar K; Sperr WR; Escribano L; Yavuz S; Reiter A; George TI; Kluin-Nelemans HC; Hermine O; Butterfield JH; Hagglund H; Ustun C; Hornick JL; Triggiani M; Radia D; Akin C; Hartmann K; Gotlib J; Schwartz LB; Verstovsek S; Orfao A; Metcalfe DD; Arock M; Horny H-P
Editorial comment: LANCET. 2014;383(9928):1608
Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis
Gulen T; Hagglund H; Dahlen S-E; Sander B; Dahlen B; Nilsson G
Review: WIENER KLINISCHE WOCHENSCHRIFT. 2012;124(23-24):807-814
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives
Valent P; Arock M; Bonadonna P; Brockow K; Broesby-Olsen S; Escribano L; Gleixner KV; Grattan C; Hadzijusufovic E; Hagglund H; Hermine O; Horny H-P; Kluin-Nelemans HC; Maurer M; Niedoszytko M; Nedoszytko B; Nilsson G; Oude-Elberink HNG; Orfao A; Radia D; Reiter A; Siebenhaar F; Sotlar K; Sperr WR; Triggiani M; VanDoormaal JJ; Varkonyi J; Yavuz S; Hartmann K
Editorial comment: MEDICAL ONCOLOGY. 2012;29(2):1231-1236
Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation
Machaczka M; Nahi H; Karbach H; Klimkowska M; Hagglund H
Letter: LEUKEMIA & LYMPHOMA. 2012;53(3):503-505
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study
Lazarevic V; Remberger M; Hagglund H; Juliusson G; Omar H; Halbook H; Kimby E; Malm C; Wahlin A; Johansson J-E
Review: LAKARTIDNINGEN. 2012;109(9-10):474-477
[Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis].
Gülen T; Gottberg L; Dahlén B; Nilsson G; Hägglund H
Editorial comment: JOURNAL OF INHERITED METABOLIC DISEASE. 2011;34(1):233-235
Gaucher disease with foamy transformed macrophages and erythrophagocytic activity
Machaczka M; Klimkowska M; Regenthal S; Hagglund H
Letter: LEUKEMIA & LYMPHOMA. 2009;50(11):1872-1874
Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?
Hallbook H; Bjorkholm M; Hagglund H; Smedmyr B
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2009;84(10):694-696
Treatment of multiple myeloma in patients with Gaucher disease
Machaczka M; Lerner R; Klimkowska M; Hagglund H
Other: LAKARTIDNINGEN. 2009;106(12):871
[Future care requires future ways of working].
Ahlberg A; Berner J; Ernestam S; Hallén K; Hägglund H; Liljegren A; Löfberg E; Martling C-R; Sarkar N; Wickström R
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2008;143(5):751-753
Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient
Nahi H; Jansson M; Sander B; Ljungman P; Hagglund H
Review: LAKARTIDNINGEN. 2008;105(46):3341-3347
[Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital].
Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G
Meeting abstract: BLOOD. 2007;110(11):2969-872A
Prospecitve quantitative PCR monitoring of allogeneic stem cell transplant (SCT) patients at high risk for EBV associated PTLD
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski JH; Yun Z; Ljungman PT
Editorial comment: MEDICAL ONCOLOGY. 2007;24(3):354-356
Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease.: Implications for its use?
Deneberg S; Lerner R; Ljungman P; Ringden O; Hagglund H
Meeting abstract: BLOOD. 2004;104(11):115B
Mobilisation and harvest of peripheral blood stem cells from 187 healthy donors. A comparison of two different Apheresis machines and three Apheresis programs
Kumlien G; Bergstrom G; Ayoub A; Kanogo L; Hagglund H
Meeting abstract: BLOOD. 2004;104(11):96B
Portal vein thrombosis a common complication following splenectomy in adults patients with CLL or myeloproliferative disease.
Svensson M; Wiren M; Kimby E; Hagglund H
Published conference paper: BONE MARROW TRANSPLANTATION. 2000;25:S6-S8
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors:: a comparison with marrow transplantation
Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau IW; Basara N; Hölig K; Beelen DW; Hägglund B; Basu O; Ehninger G; Fauser AA
Letter: TRANSPLANTATION. 1998;66(1):142-143
Transplantation of peripheral blood progenitor cells from unrelated donors
Ringdén O; Runde V; Hägglund H; Basu O; Potter M
Published conference paper: BONE MARROW TRANSPLANTATION. 1998;21:S81-S84
Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors
Ringdén O; Hägglund H; Runde V; Basu O; Kroschinsky F; Stockschläder M; Potter MN
Doctoral thesis: 1998
Risk-factors, prevention and treatment of early complications after allogeneic haematopoietic stem cell transplantation
Hägglund H
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3147-3149
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia
Carlens S; Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3145-3146
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age
Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Carlens S; Lonnqvist B; Sparrelid E; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):735-736
A low incidence of grade II to IV acute GVHD, but high mortality from, infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate
Mattsson J; Ringden O; Aschan J; Barkholt L; Dalianis T; Hagglund H; Ljungman P; Lonnqvist B; Tollemar J; Winiarski J; Remberger M
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;17:S62-S64
Transplantation of peripheral blood progenitor cells from unrelated donors
Ringden O; Potter MN; Oakhill A; Cornish J; Hagglund H; Lonnqvist B; Shanwell A; Winiarski J; Pamphilon DH
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3535
No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ljungman P; Winiarski J; Ericzon B; Tyden G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3531-3532
Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: The experience at Huddinge Hospital
Aschan J; Ringden O; Ljungman P; Hagglund H; Klaesson S; Dalianis T; Remberger M
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3530
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation
Sparrelid E; Hagglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringden O
Letter: BONE MARROW TRANSPLANTATION. 1995;16(6):856-857
Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease
Ringden O; Lonnqvist B; Hagglund H; Ljungman P; Shanwell A; Lawlor E; Schmitz N
Visa fler

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI